Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes
α-氨基己二酸 (2-AAA) 的决定因素及其与糖尿病的关系
基本信息
- 批准号:10164763
- 负责人:
- 金额:$ 46.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAmino AcidsAnimalsBiologicalBiological MarkersBiologyBloodBlood specimenCardiometabolic DiseaseCatabolismCause of DeathCohort StudiesCommunitiesComplications of Diabetes MellitusComputerized Medical RecordControlled StudyDNADataDevelopmentDiabetes MellitusDietDietary InterventionDiseaseDisease MarkerEarly identificationEpidemiologyFastingFood InteractionsFramingham Heart StudyFunctional disorderFutureGeneral PopulationGenesGeneticGenetic DeterminismGenetic RiskGenotypeGenotype-Tissue Expression ProjectHealthHealth Care CostsHigh PrevalenceHumanIncidenceIndividualIntakeInvestigationJackson Heart StudyKnowledgeLysineMeasurementMeasuresMedical GeneticsMeta-AnalysisMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMorbidity - disease rateOutcome StudyParticipantPathogenesisPathway interactionsPatient Self-ReportPhenotypePlasmaPopulationProtocols documentationRandomizedResearchRiskRisk FactorsRisk MarkerRoleSamplingTestingTissue-Specific Gene ExpressionTissuesTracerValidationVariantWomen&aposs Healthbiobankcohortcomorbiditycostdiabetes pathogenesisdiabetes prevention programdiabetes riskdietaryfallsfollow-upgenetic architecturegenetic predictorsgenome wide association studyglobal healthimprovedinsightinsulin secretionmenmetabolomicsmortalitymulti-ethnicnew therapeutic targetnovelprotein intakerecruitstable isotopetargeted treatmenttherapeutic development
项目摘要
Diabetes is a major global health concern, associated with significantly increased mortality and high incidence
of co-morbidities. The lysine-derived metabolite α-aminoadipic acid (2-AAA) was identified as a novel predictor
of diabetes development in Framingham Heart Study (FHS) participants and validation samples (N~2,000). In
these subjects, increased plasma 2-AAA in healthy individuals was associated with increased future risk of
diabetes (12-year follow-up), identifying at-risk individuals even after adjustment for known risk factors. Several
subsequent studies have confirmed the association between 2-AAA and diabetes, but the mechanisms remain
unknown. Preliminary data support a role for 2-AAA in insulin secretion and diabetes pathophysiology, and
suggest genetic determinants of 2-AAA relate to diabetes and diabetic complications. However it is not yet
clear whether 2-AAA is itself causal in diabetes development, or is a biomarker for altered metabolic
processes. Many questions remain as to mechanisms of action. In this proposal, we will examine the
determinants of 2-AAA, by studying lysine-2-AAA metabolism in subjects with extreme levels of 2-AAA before
and after dietary intervention (Aim 1); identify the genetic predictors of 2-AAA (Aim 2); and examine the genetic
architecture of 2-AAA and disease (Aim 3). These aims will advance our long-term research objective, to
understand determinants of 2-AAA, and establish utility of 2-AAA and related pathways as a novel therapeutic
target in diabetes.
糖尿病是一个主要的全球健康问题,与显著增加的死亡率和高发病率有关
并存的疾病。赖氨酸代谢产物α-氨基己二酸(2-aaa)被认为是一种新的预测因子
弗雷明翰心脏研究(FHS)参与者和验证样本(N~2,000)中糖尿病发展的预测。在……里面
在这些受试者中,健康个体血浆中2-AAA的升高与未来发生糖尿病的风险增加相关。
糖尿病(12年随访),即使在对已知风险因素进行调整后也能识别高危个体。几个
后来的研究证实了2-AAA和糖尿病之间的联系,但其机制仍然存在
未知。初步数据支持2-AAA在胰岛素分泌和糖尿病病理生理中的作用
提示2-AAA的遗传决定因素与糖尿病及糖尿病并发症有关。然而,它还没有
明确2-AAA本身是糖尿病发生的原因,还是代谢改变的生物标记物
流程。关于行动机制,仍然存在许多问题。在这项建议中,我们将研究
通过研究2-AAA极端水平受试者的赖氨酸-2-AAA代谢,研究2-AAA的决定因素
和饮食干预后(目标1);确定2-AAA的遗传预测因素(目标2);并检查
2-AAA与疾病的结构(目标3)。这些目标将推动我们的长期研究目标,以
了解2-AAA的决定因素,并建立2-AAA及其相关通路作为一种新的治疗方法的实用性
糖尿病的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jane F Ferguson其他文献
Jane F Ferguson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jane F Ferguson', 18)}}的其他基金
The role of alpha-aminoadipic acid (2-AAA) in residual CVD risk in T2D
α-氨基己二酸 (2-AAA) 在 T2D 残余 CVD 风险中的作用
- 批准号:
10713291 - 财政年份:2023
- 资助金额:
$ 46.56万 - 项目类别:
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology
虚拟代谢组学作为新型心脏代谢疾病生物学的发现工具
- 批准号:
9883038 - 财政年份:2019
- 资助金额:
$ 46.56万 - 项目类别:
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology
虚拟代谢组学作为新型心脏代谢疾病生物学的发现工具
- 批准号:
10414765 - 财政年份:2019
- 资助金额:
$ 46.56万 - 项目类别:
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology
虚拟代谢组学作为新型心脏代谢疾病生物学的发现工具
- 批准号:
10606582 - 财政年份:2019
- 资助金额:
$ 46.56万 - 项目类别:
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetes
α-氨基己二酸 (2-AAA) 的决定因素及其与糖尿病的关系
- 批准号:
10447054 - 财政年份:2018
- 资助金额:
$ 46.56万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 46.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 46.56万 - 项目类别:
Operating Grants














{{item.name}}会员




